TAG Episode 31 - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

TAG Episode 31 - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma.

Read More

TAG Episode 30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

TAG Episode 30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

In this episode, I talk with Murray Johnstone from Seattle about pulsatile flow through the Trabecular Meshwork and collector channels. We discuss the imaging improvements over the years that have made this possible including the latest phase-based OCT scans that result in nanometre resolution instead of the micrometre resolution of spectral domain scans that most of us are using  in clinical practice.

Read More

TAG Episode 25 - 29Feb2016: Nelson Winkler & Cheryl Khanna Team Based Glaucoma Care (AAC Enhanced)

TAG Episode 25 - 29Feb2016: Nelson Winkler & Cheryl Khanna Team Based Glaucoma Care (AAC Enhanced)

In this episode, I talk with Nelson Winkler (a medical student at the time) and Cheryl Khanna (Glaucoma attending) at The Mayo Clinic, who analyzed the outcomes of their team based model for Glaucoma care...

Read More